These 3 Dividend Stocks Are Immune to the Coronavirus Crisis
Philip Morris International and two other stocks are well insulated from the coronavirus headwinds.
2 Dividend Stocks to Bankroll Your Retirement
Big yields from financially strong companies with industry-leading positions, that's how you should bankroll your retirement.
5 Important Takeaways From Walmart's Soft Holiday Quarter
Even with solid e-commerce growth, Walmart wasn't able to measure up to expectations.
The company, which is pending a buyout by Curaleaf, sells 10 properties in a sale-leaseback arrangement.
It's a disappointing setback for a drug that has received previous approvals for similar conditions.
Senate Bill 165 sails through a judiciary committee vote.
CVS has seen remarkable gains over the trailing twelve months, mostly thanks to its nearly $70 billion purchase of Aetna at the end of 2018. Should investors buy now?
Shares of the home goods retailer rose as new management took initial steps to repair the business.
The state's tax revenue from the drug also reached an all-time high.
Revenue was more than $5 million higher than analysts were expecting.
The Truly brand continues to expand volume at a market-crushing pace.
It's possible that short-sellers are covering shares heading into the company's fourth-quarter earnings next week.
The Chinese education company extended yesterday's post-earnings gains.
Shares rise after the company received some bullish praise from a Wall Street analyst.
The tobacco company still believes it will improve profitability by 4% to 7% over its next three fiscal years.
An industry peer echoed SunPower's previous comments that, at this time, the coronavirus epidemic in China isn't expected to have a major impact on first-quarter 2020 operations.
Last year was a good one for big data companies, but Alteryx stood out as one of the biggest winners.
The cannabis company is the proud new owner of Arizona Natural Selections.
The biopharma is scheduled to update investors and Wall Street analysts on two important pipeline programs on Feb. 20.
The high-yielding MLP's headwinds have worsened.
P&G's skincare brand has made a commitment to have zero skin-retouching in its ads by 2021.
Investors reacted enthusiastically to a positive coverage decision for the company's Eversense CGM device.
An upgrade by one analyst and a big earnings report from a competitor has investors buying today.